SLC38A10 and neurodegenerative disease: In conclusion, the SLC38A10 knockout model revealed the new finding of SLC38A10 in glutamate metabolism, mTOR dependent protein and fatty acid regulation, supporting a previous association between SLC38A10 polymorphisms and neurodegenerative diseases.